Literature DB >> 20220046

Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes.

Petra M Jauslin1, Nicolas Frey, Mats O Karlsson.   

Abstract

A model able to simultaneously characterize and simulate 24-hour glucose and insulin profiles following multiple meal tests was developed, extending an integrated glucose-insulin model for oral glucose tolerance tests that was previously published. The analysis was based on glucose and insulin measurements from 59 placebo-treated patients with type 2 diabetes. Circadian variations in glucose homeostasis were assessed on relevant parameters based on literature review. They were best described by a nighttime dip in insulin secretion between approximately 9 p.m. and 5 a.m. using a modulator function. The integrated glucose-insulin model has thus been shown to be applicable to real-life situations determined by multiple meals over the course of a day. This provides the basis for the analysis and simulation of long-term glucose and insulin data. The model may also prove useful for understanding antidiabetic drug actions and requirements in the context of circadian changes in glucose-insulin regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220046     DOI: 10.1177/0091270010362536

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  12 in total

Review 1.  A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development.

Authors:  Puneet Gaitonde; Parag Garhyan; Catharina Link; Jenny Y Chien; Mirjam N Trame; Stephan Schmidt
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

2.  Exploring inductive linearization for pharmacokinetic-pharmacodynamic systems of nonlinear ordinary differential equations.

Authors:  Chihiro Hasegawa; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-05-26       Impact factor: 2.745

3.  Assessment of glycemic response to an oral glucokinase activator in a proof of concept study: application of a semi-mechanistic, integrated glucose-insulin-glucagon model.

Authors:  Karen B Schneck; Xin Zhang; Robert Bauer; Mats O Karlsson; Vikram P Sinha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-22       Impact factor: 2.745

4.  Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.

Authors:  Xin Zhang; Karen Schneck; Juliana Bue-Valleskey; Kwee Poo Yeo; Michael Heathman; Vikram Sinha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-22       Impact factor: 2.745

5.  Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment.

Authors:  Joanna Parkinson; Bengt Hamrén; Maria C Kjellsson; Stanko Skrtic
Journal:  Br J Clin Pharmacol       Date:  2016-08-16       Impact factor: 4.335

6.  Influence of Meals and Glycemic Changes on QT Interval Dynamics.

Authors:  Brenda Cirincione; Philip T Sager; Donald E Mager
Journal:  J Clin Pharmacol       Date:  2017-05-22       Impact factor: 3.126

7.  Study Design Selection in Early Clinical Anti-Hyperglycemic Drug Development: A Simulation Study of Glucose Tolerance Tests.

Authors:  Moustafa M A Ibrahim; Siti M S Ghadzi; Maria C Kjellsson; Mats O Karlsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-05-06

Review 8.  Mathematical Modeling for the Physiological and Clinical Investigation of Glucose Homeostasis and Diabetes.

Authors:  Andrea Mari; Andrea Tura; Eleonora Grespan; Roberto Bizzotto
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

9.  The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model.

Authors:  R M Røge; S Klim; S H Ingwersen; M C Kjellsson; N R Kristensen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-12-30

10.  Toward Better Understanding of Insulin Therapy by Translation of a PK-PD Model to Visualize Insulin and Glucose Action Profiles.

Authors:  Karen Schneck; Lai San Tham; Ali Ertekin; Jesus Reviriego
Journal:  J Clin Pharmacol       Date:  2018-10-19       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.